Natural products industry companies share overviews on the latest science on their branded ingredients and formulations to ...

MSD’s HIV treatment is now back on track after an earlier hit which saw the FDA place a clinical hold on the therapy.

New data from the MK-8591A-051 and MK-8591A-052 trials, both investigating the efficacy and safety of 100-mg doravirine and 0.25-mg islatravir as a once-daily 2-drug regimen for virologically ...

Galcanezumab provided greater reductions in migraine frequency, resulting in a shift from chronic to episodic migraine over a 12-month period compared with placebo.

Magnesium and melatonin are commonly used as sleep aids, though their effects are generally modest. Learn how they work and ...

Topline data were announced from a phase 3 trial evaluating ecopipam in pediatric and adult patients with Tourette syndrome.

Weight loss supplements are a big industry, but do they actually work? A dietitian explores the evidence, efficacy, and safety of common weight loss supplements.

Mind Medicine (MindMed) Inc. ( NASDAQ: MNMD) Q4 2024 Earnings Conference Call March 6, 2025 8:00 AM ET Stephanie Fagan - Chief Corporate Affairs Officer Rob Barrow - CEO Dan Karlin - CMO ...

Biodexa Pharmaceuticals (BDRX) announced the appointment of Precision for Medicine as the clinical research organization, CRO, to conduct the ...

According to a randomized, double-blind, double-dummy human laboratory trial conducted by researchers from researchers from ...

An international collaboration of researchers, sponsored by GSK and working on behalf of the ANCHOR-1 and ANCHOR-2 trial ...

A new study shows that Americans’ risk of developing dementia after turning 55 is more than double what earlier research had found. The New York University study estimates that the number of dementia ...